Case Series: Cariprazine for treatment of methamphetamine use disorder

Case Series: Cariprazine for treatment of methamphetamine use disorder

Background and Objectives Methamphetamine use is a major source of morbidity and mortality but has no reliably effective interventions. We identified cariprazine as an option for treatment of methamphetamine use disorder (MUD) and present two cases. Methods Two patients with MUD and psychotic disord...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal on addictions 2022-01, Vol.31 (1), p.85-88
Hauptverfasser: Truong, Thanh Thuy, Li, Benjamin
Format: Artikel
Sprache:eng
Schlagworte:
Craving
Humans
Methamphetamine - adverse effects
Piperazines - pharmacology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 88
container_issue 1
container_start_page 85
container_title The American journal on addictions
container_volume 31
creator Truong, Thanh Thuy
Li, Benjamin
description Background and Objectives Methamphetamine use is a major source of morbidity and mortality but has no reliably effective interventions. We identified cariprazine as an option for treatment of methamphetamine use disorder (MUD) and present two cases. Methods Two patients with MUD and psychotic disorders were treated with cariprazine. Abstinence and cravings were assessed using urine drug screens and the Brief Substance Craving Scale, respectively. Results Both patients reported global functional improvement, reduction in methamphetamine cravings and use with cariprazine, confirmed with negative urine drug screens. Conclusions and Scientific Significance Cariprazine's unique pharmacodynamic profile conveys potential efficacy for MUD. It would be a novel treatment that targets multiple psychiatric symptoms seen in MUD.
doi_str_mv 10.1111/ajad.13241
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_ajad_13241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AJAD13241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2961-d0d5ce334df31593b721160cb27618623cf1d7045302d811568c85288765ba503</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK1e_AGyZyF1Z7-y8Vai9YOCB_UcNtkJTWmasJsi9debGPXoe5k5PPPCPIRcAptDnxu7sW4Ogks4IlNQHCImEjjud6ZUxGSiJ-QshA3rYxJ9SiZCxiASKaZkmdqA9BV9heGWptZXrbef1Q5p2XjaebRdjbuONiWtsVvbul1jZ-sB2PeHrgqNd-jPyUlptwEvfuaMvC_v39LHaPXy8JQuVlHBEw2RY04VKIR0pQCViDzmAJoVOY81GM1FUYKLmVSCcWcAlDaFUdyYWKvcKiZm5HrsLXwTgscya31VW3_IgGWDjGyQkX3L6OGrEW73eY3uD_39vgdgBD6qLR7-qcoWz4u7sfQLZCFn_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Case Series: Cariprazine for treatment of methamphetamine use disorder</title><source>MEDLINE</source><source>Wiley Online Library</source><creator>Truong, Thanh Thuy ; Li, Benjamin</creator><creatorcontrib>Truong, Thanh Thuy ; Li, Benjamin</creatorcontrib><description>Background and Objectives Methamphetamine use is a major source of morbidity and mortality but has no reliably effective interventions. We identified cariprazine as an option for treatment of methamphetamine use disorder (MUD) and present two cases. Methods Two patients with MUD and psychotic disorders were treated with cariprazine. Abstinence and cravings were assessed using urine drug screens and the Brief Substance Craving Scale, respectively. Results Both patients reported global functional improvement, reduction in methamphetamine cravings and use with cariprazine, confirmed with negative urine drug screens. Conclusions and Scientific Significance Cariprazine's unique pharmacodynamic profile conveys potential efficacy for MUD. It would be a novel treatment that targets multiple psychiatric symptoms seen in MUD.</description><identifier>ISSN: 1055-0496</identifier><identifier>EISSN: 1521-0391</identifier><identifier>DOI: 10.1111/ajad.13241</identifier><identifier>PMID: 34713943</identifier><language>eng</language><publisher>England</publisher><subject>Craving ; Humans ; Methamphetamine - adverse effects ; Piperazines - pharmacology</subject><ispartof>The American journal on addictions, 2022-01, Vol.31 (1), p.85-88</ispartof><rights>2021 American Academy of Addiction Psychiatry</rights><rights>2021 American Academy of Addiction Psychiatry.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2961-d0d5ce334df31593b721160cb27618623cf1d7045302d811568c85288765ba503</citedby><cites>FETCH-LOGICAL-c2961-d0d5ce334df31593b721160cb27618623cf1d7045302d811568c85288765ba503</cites><orcidid>0000-0003-0931-7306</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajad.13241$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajad.13241$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34713943$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Truong, Thanh Thuy</creatorcontrib><creatorcontrib>Li, Benjamin</creatorcontrib><title>Case Series: Cariprazine for treatment of methamphetamine use disorder</title><title>The American journal on addictions</title><addtitle>Am J Addict</addtitle><description>Background and Objectives Methamphetamine use is a major source of morbidity and mortality but has no reliably effective interventions. We identified cariprazine as an option for treatment of methamphetamine use disorder (MUD) and present two cases. Methods Two patients with MUD and psychotic disorders were treated with cariprazine. Abstinence and cravings were assessed using urine drug screens and the Brief Substance Craving Scale, respectively. Results Both patients reported global functional improvement, reduction in methamphetamine cravings and use with cariprazine, confirmed with negative urine drug screens. Conclusions and Scientific Significance Cariprazine's unique pharmacodynamic profile conveys potential efficacy for MUD. It would be a novel treatment that targets multiple psychiatric symptoms seen in MUD.</description><subject>Craving</subject><subject>Humans</subject><subject>Methamphetamine - adverse effects</subject><subject>Piperazines - pharmacology</subject><issn>1055-0496</issn><issn>1521-0391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRbK1e_AGyZyF1Z7-y8Vai9YOCB_UcNtkJTWmasJsi9debGPXoe5k5PPPCPIRcAptDnxu7sW4Ogks4IlNQHCImEjjud6ZUxGSiJ-QshA3rYxJ9SiZCxiASKaZkmdqA9BV9heGWptZXrbef1Q5p2XjaebRdjbuONiWtsVvbul1jZ-sB2PeHrgqNd-jPyUlptwEvfuaMvC_v39LHaPXy8JQuVlHBEw2RY04VKIR0pQCViDzmAJoVOY81GM1FUYKLmVSCcWcAlDaFUdyYWKvcKiZm5HrsLXwTgscya31VW3_IgGWDjGyQkX3L6OGrEW73eY3uD_39vgdgBD6qLR7-qcoWz4u7sfQLZCFn_g</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Truong, Thanh Thuy</creator><creator>Li, Benjamin</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-0931-7306</orcidid></search><sort><creationdate>202201</creationdate><title>Case Series: Cariprazine for treatment of methamphetamine use disorder</title><author>Truong, Thanh Thuy ; Li, Benjamin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2961-d0d5ce334df31593b721160cb27618623cf1d7045302d811568c85288765ba503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Craving</topic><topic>Humans</topic><topic>Methamphetamine - adverse effects</topic><topic>Piperazines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Truong, Thanh Thuy</creatorcontrib><creatorcontrib>Li, Benjamin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The American journal on addictions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Truong, Thanh Thuy</au><au>Li, Benjamin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case Series: Cariprazine for treatment of methamphetamine use disorder</atitle><jtitle>The American journal on addictions</jtitle><addtitle>Am J Addict</addtitle><date>2022-01</date><risdate>2022</risdate><volume>31</volume><issue>1</issue><spage>85</spage><epage>88</epage><pages>85-88</pages><issn>1055-0496</issn><eissn>1521-0391</eissn><abstract>Background and Objectives Methamphetamine use is a major source of morbidity and mortality but has no reliably effective interventions. We identified cariprazine as an option for treatment of methamphetamine use disorder (MUD) and present two cases. Methods Two patients with MUD and psychotic disorders were treated with cariprazine. Abstinence and cravings were assessed using urine drug screens and the Brief Substance Craving Scale, respectively. Results Both patients reported global functional improvement, reduction in methamphetamine cravings and use with cariprazine, confirmed with negative urine drug screens. Conclusions and Scientific Significance Cariprazine's unique pharmacodynamic profile conveys potential efficacy for MUD. It would be a novel treatment that targets multiple psychiatric symptoms seen in MUD.</abstract><cop>England</cop><pmid>34713943</pmid><doi>10.1111/ajad.13241</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-0931-7306</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1055-0496
ispartof The American journal on addictions, 2022-01, Vol.31 (1), p.85-88
issn 1055-0496
1521-0391
language eng
recordid cdi_crossref_primary_10_1111_ajad_13241
source MEDLINE; Wiley Online Library
subjects Craving
Humans
Methamphetamine - adverse effects
Piperazines - pharmacology
title Case Series: Cariprazine for treatment of methamphetamine use disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A10%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20Series:%20Cariprazine%20for%20treatment%20of%20methamphetamine%20use%20disorder&rft.jtitle=The%20American%20journal%20on%20addictions&rft.au=Truong,%20Thanh%20Thuy&rft.date=2022-01&rft.volume=31&rft.issue=1&rft.spage=85&rft.epage=88&rft.pages=85-88&rft.issn=1055-0496&rft.eissn=1521-0391&rft_id=info:doi/10.1111/ajad.13241&rft_dat=%3Cwiley_cross%3EAJAD13241%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34713943&rfr_iscdi=true